Albion Financial Group UT maintained its stake in Stericycle, Inc. (NASDAQ:SRCL) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,117 shares of the business services provider’s stock at the end of the 2nd quarter. Albion Financial Group UT’s holdings in Stericycle were worth $391,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the business. Vanguard Group Inc. raised its position in Stericycle by 3.0% during the second quarter. Vanguard Group Inc. now owns 8,334,537 shares of the business services provider’s stock valued at $636,092,000 after purchasing an additional 240,327 shares during the period. BlackRock Inc. raised its position in Stericycle by 6.4% during the second quarter. BlackRock Inc. now owns 5,413,244 shares of the business services provider’s stock valued at $413,139,000 after purchasing an additional 323,664 shares during the period. State Street Corp raised its position in Stericycle by 1.1% during the first quarter. State Street Corp now owns 3,470,873 shares of the business services provider’s stock valued at $287,693,000 after purchasing an additional 39,382 shares during the period. FMR LLC raised its position in Stericycle by 8.2% during the first quarter. FMR LLC now owns 2,925,407 shares of the business services provider’s stock valued at $242,486,000 after purchasing an additional 221,262 shares during the period. Finally, Fairpointe Capital LLC raised its position in Stericycle by 14.5% during the first quarter. Fairpointe Capital LLC now owns 2,391,424 shares of the business services provider’s stock valued at $198,225,000 after purchasing an additional 302,369 shares during the period. Institutional investors and hedge funds own 93.57% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Albion Financial Group UT Continues to Hold Holdings in Stericycle, Inc. (SRCL)” was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this piece of content can be read at https://www.thecerbatgem.com/2017/10/12/albion-financial-group-ut-continues-to-hold-holdings-in-stericycle-inc-srcl.html.

A number of brokerages have issued reports on SRCL. Jefferies Group LLC set a $108.00 price objective on Stericycle and gave the company a “buy” rating in a research report on Friday, August 11th. BidaskClub downgraded Stericycle from a “sell” rating to a “strong sell” rating in a research report on Tuesday, August 1st. Barclays PLC restated an “overweight” rating and set a $100.00 price objective on shares of Stericycle in a research report on Wednesday, August 9th. Zacks Investment Research downgraded Stericycle from a “hold” rating to a “sell” rating in a research report on Wednesday, October 4th. Finally, BMO Capital Markets assumed coverage on Stericycle in a report on Thursday, June 29th. They issued a “market perform” rating and a $81.00 price target on the stock. Four investment analysts have rated the stock with a sell rating, four have given a hold rating and six have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $81.25.

Shares of Stericycle, Inc. (SRCL) traded up 1.65% during midday trading on Thursday, hitting $71.88. The stock had a trading volume of 242,916 shares. The firm’s 50 day moving average price is $71.23 and its 200 day moving average price is $77.63. The firm’s market cap is $6.13 billion. Stericycle, Inc. has a 52-week low of $68.62 and a 52-week high of $88.00.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings results on Thursday, August 3rd. The business services provider reported $1.15 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.13 by $0.02. The firm had revenue of $917.70 million for the quarter, compared to analyst estimates of $902.81 million. Stericycle had a negative net margin of 0.07% and a positive return on equity of 14.35%. The business’s revenue for the quarter was up 2.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.18 EPS. On average, equities research analysts expect that Stericycle, Inc. will post $4.59 earnings per share for the current year.

Stericycle Profile

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Stock Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related stocks with our FREE daily email newsletter.